MK-801 prevents dopamine DI but not serotonin 2A stimulation of striatal preprotachykinin mRNA expression

被引:12
作者
Campbell, BM
Walker, PD
机构
[1] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Cellular & Clin Neurobiol Program, Detroit, MI 48201 USA
关键词
basal ganglia; gene regulation; Parkinson's disease; tachykinin;
D O I
10.1097/00001756-200104170-00018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We examined dopamine (DA) and serotonin (5-HT) receptor-mediated influences on striatal preprotachykinin (PPT, tachykinin precursor) mRNA regulation in organotypic slice cultures. A 3 h exposure to SKF-38393 (10 muM, DA D-1 agonist) or DOI (10 muM, 5-HT2 agonist) increased PPT mRNA levels to 196.4% and 154.0%, respectively. Responses to SKF-38393 were prevented by SCH-23390(10 muM D-1 antagonist) whereas DOI-stimulated increases were prevented by ketanserin (10 muM, 5-HT2A antagonist). Since striatal tachykinin neurons also possess NMDA receptors that regulate gene expression, stimulation of PPT message levels was examined in the presence of MK-801, a non-competitive NMDA antagonist. Alone, MK-801 (10 nM) did not significantly alter basal PPT message levels. However, MK-801 prevented SKF-38393-stimulated increases in PPT mRNA expression while DOI-induced expression was not affected. These results provide evidence that D-1 regulation of striatal tachykinin expression is dependent on NMDA-type glutamate neurotransmission while 5HT(2A) regulation appears independent. NeuroReport 12:953-955 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:953 / 955
页数:3
相关论文
共 23 条
[1]   Suppression of serotonin hyperinnervation does not alter the dysregulatory influences of dopamine depletion on striatal neuropeptide gene expression in rodent neonates [J].
Basura, GJ ;
Walker, PD .
NEUROSCIENCE LETTERS, 1999, 274 (01) :9-12
[2]   A complex program of striatal gene expression induced by dopaminergic stimulation [J].
Berke, JD ;
Paletzki, RF ;
Aronson, GJ ;
Hyman, SE ;
Gerfen, CR .
JOURNAL OF NEUROSCIENCE, 1998, 18 (14) :5301-5310
[3]   Adjuncts to dopamine replacement: A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease [J].
Brotchie, JM .
MOVEMENT DISORDERS, 1998, 13 (06) :871-876
[4]   Striatal preprotachykinin mRNA levels are regulated by stimulatory agents and dopamine D1 receptor manipulation in rodent organotypic slice cultures [J].
Campbell, BM ;
Walker, PD .
BRAIN RESEARCH, 2001, 888 (01) :26-33
[5]   D1 AND D2 DOPAMINE RECEPTOR REGULATED GENE-EXPRESSION OF STRIATONIGRAL AND STRIATOPALLIDAL NEURONS [J].
GERFEN, CR ;
ENGBER, TM ;
MAHAN, LC ;
SUSEL, Z ;
CHASE, TN ;
MONSMA, FJ ;
SIBLEY, DR .
SCIENCE, 1990, 250 (4986) :1429-1432
[6]   Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease [J].
Gresch, PJ ;
Walker, PD .
NEUROSCIENCE, 1999, 93 (03) :831-841
[7]  
Iravani MM, 1999, SYNAPSE, V32, P212, DOI 10.1002/(SICI)1098-2396(19990601)32:3<212::AID-SYN7>3.3.CO
[8]  
2-D
[9]   EFFECTS OF SUBSTANCE-P INJECTED INTO THE SUBSTANTIA NIGRA [J].
JAMES, TA ;
STARR, MS .
BRITISH JOURNAL OF PHARMACOLOGY, 1979, 65 (03) :423-429
[10]   Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: Evidence for involvement of pharmacologically distinct NMDA receptors? [J].
Keefe, KA ;
Ganguly, A .
DEVELOPMENTAL NEUROSCIENCE, 1998, 20 (2-3) :216-228